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Abstract: Two new eunicellin-type diterpenoids, cladielloides A (1) and B (2), which were 
found to possess a 2-hydroxybutyroxy group in their structures, were isolated from an 
Indonesian octocoral identified as Cladiella sp. The structures of eunicellins 1 and 2 were 
elucidated by spectroscopic methods. Cladielloide B (2) exhibited moderate cytotoxicity 
toward CCRF-CEM tumor cells and this compound displayed significant inhibitory effects 
on superoxide anion generation and elastase release by human neutrophils.  
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1. Introduction 
Previous chemical investigations on the octocorals belonging to the genus Cladiella have resulted in 
a  series  of  interesting  eunicellin-based  (2,11-cyclized  cembranoid)  diterpenoids  [1–6],  and  the 
compounds  of  this  type  have  been  found  to  possess  complex  structures  and  various  
bioactivities  [1–3,5–11].  In  continuation  of  our  search  for  bioactive  substances  from  the  marine 
invertebrates  distributed  in  the  tropical  West  Pacific  Ocean,  an  Indonesian  octocoral  identified  as 
Cladiella  sp.  was  studied,  and  its  organic  extract  exhibited  cytotoxicity  toward  DLD-1  (human 
colorectal  adenocarcinoma),  HL-60  (human  promyelocytic  leukemia  cells),  and  P388D1 
(macrophage-like  murine  tumor  cells),  with  IC50  =  2.7,  8.9,  7.2  g/mL,  respectively.  Two  new 
eunicellins, cladielloides A (1) and B (2), were isolated from this marine organism. In this paper, we 
report the isolation, structure determination, and bioactivity of the above new diterpenoids 1 and 2 
(Scheme 1). 
Scheme 1. The structures of cladielloides A (1) and B (2).  
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2. Results and Discussion 
Cladielloide A (1) was isolated as a colorless oil and the molecular formula for this compound was 
determined  to  be  C26H40O7  (seven  degrees  of  unsaturation)  by  HRESIMS  (C26H40O7  +  Na, 
m/z 487.2674, calculated 487.2672). The  IR spectrum of 1 showed bands at 3460 and 1734 cm
−1, 
consistent with the presence of hydroxy and ester groups. From the 
1H and 
13C NMR spectra (Table 1), 
1 was found to possess a trisubstituted olefin (H 5.43, 1H, m, H-12; C 132.1, s, C-11; 122.2, d, C-12), 
an exocyclic carbon-carbon double bond (H 5.21, 1H, s, H-16a; 5.58, 1H, s, H-16b; C 147.6, s, C-7; 
115.2, t, C-16), an acetoxy group (H 2.14, 3H, s; C 20.6, q; 171.1, s), and a 2-hydroxybutyrate 
(H 1.03, 3H, t, J = 7.2 Hz; 1.91, 2H, m; 4.86, 1H, dd, J = 6.8, 6.0 Hz; C 9.3, q; 24.3, t; 74.1, d; 171.4, s) 
moiety. Thus, from the above data, four degrees of unsaturation were accounted for and compound 1 
must be a tricyclic compound. 
In the 
1H NMR spectrum of 1, two doublets at H 0.92 and 0.83 (each 3H, d, J = 6.4 Hz, H3-19 and 
H3-20) were deduced from two methyls of an isopropyl group. A singlet of the tertiary methyl bonded Mar. Drugs 2010, 8  
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to an oxygenated carbon was due to the resonance of signal at H 1.37 (3H, s, H3-15). In addition, a 
suite of resonances of proton signals at H 2.74 (1H, m, H-1), 2.63 (1H, br s, H-10), 3.86 (1H, d, 
J = 8.0 Hz, H-2), 4.16 (1H, dt, J = 3.6, 3.2 Hz, H-9), and carbon signals at C 39.7 (d, C-1), 44.6 (d, C-10), 
87.1 (d, C-2), and 81.3 (d, C-9), indicated the presence of a tetrahydrofuran structural unit. Based on 
the above data, the proposed skeleton of 1 was suggested to be a eunicellin-based metabolite. 
Table 1. 
1H and 
13C NMR data, 
1H–
1H COSY, and HMBC correlations for diterpenoid 1. 
C/H 
1H 
a  
13C 
b  
1H–
1H COSY  HMBC (H→C) 
1  2.74 m  39.7  (d) 
d  H-2, H-10, H-14  C-2, -3, -10, -11, -14 
2  3.86 d (8.0) 
c  87.1  (d)  H-1  C-3, -4, -9, -14, -15 
3    74.6  (s)     
4  5.14 dd (4.4, 3.6)  74.4  (d)  H2-5  C-3, -6, -15, -23 
5
 
2.97 ddd (16.0, 4.4, 2.8) 
1.75 ddd (16.0, 5.6, 3.6) 
37.2  (t)  H-4, H-5, H-6 
H-4, H-5, H-6 
C-3, -4 
C-4, -6, -7 
6  4.21 br s  72.6  (d)  H2-5, OH-6  n.o. 
e 
7    147.6  (s)     
8  2.35 br d (2.4)  40.0  (t)  H-9  C-6, -7, -9, -10, -16 
9  4.16 dt (3.6, 3.2)  81.3  (d)  H2-8, H-10  n.o. 
10  2.63 br s  44.6  (d)  H-1, H-9  C-11 
11    132.1  (s)     
12  5.43 m  122.2  (d)  H2-13, H3-17  n.o. 
13
 
2.10 m 
1.97 m 
22.8  (t)  H-12, H-13, H-14
H-12, H-13, H-14 
n.o. 
n.o. 
14  1.58 m  39.0  (d)  H-1, H2-13, H-18  n.o. 
15  1.37 s  22.4  (q)    C-2, -3, -4 
16a 
b 
5.21 s 
5.58 s 
115.2  (t)  H-16b 
H-16a 
C-6, -8 
C-6, -7, -8 
17  1.68 d (0.8)  22.0  (q)  H-12  C-10, -11, -12 
18  1.62 m  28.8  (d)  H-14, H3-19, H3-20  C-1, -14 
19  0.92 d (6.4)  21.3  (q)  H-18  C-14, -18, -20 
20  0.83 d (6.4)  20.5  (q)  H-18  C-14, -18, -19 
OH-6  2.84 d (7.2)      H-6  n.o. 
3-OC(O)CH3 
21 22 
 
2.14 s 
171.1 
20.6 
(s) 
(q) 
   
C-21 
OCCHCH2CH3
O
OH
4-
23
24 25 26
 
 
4.86 dd (6.8, 6.0) 
1.91 m 
1.03 t (7.2) 
171.4 
74.1 
24.3 
9.3 
(s) 
(d) 
(t) 
(q) 
 
H2-25 
H-24, H3-26 
H2-25 
 
C-23, -25, -26 
C-23, -24, -26 
C-24, -25 
a Spectra measured at 400 MHz in CDCl3 at 25 °C ; 
b Spectra measured at 100 MHz in CDCl3 at 
25 °C ; 
c J values (in hertz) in parentheses; 
d Attached protons were deduced by DEPT and HMQC 
experiments; 
e n.o. = not observed.  
From the 
1H–
1H COSY spectrum of 1, it was possible to identify the separate spin systems among 
H-1/H-2;  H-4/H2-5/H-6;  H2-8/H-9/H-10;  and  H-10/H-1  (Table  1).  These  data,  together  with  the 
HMBC correlations between H-1/C-2, -3, -10; H-2/C-3, -4, -9; H-4/C-3, -6; H2-5/C-3, -4, -6, -7; and 
H2-8/C-6, -7, -9, -10, established the connectivity from C-1 to C-10 within the ten-membered ring Mar. Drugs 2010, 8  
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(Table 1). An exocyclic carbon-carbon double bond at C-7 was confirmed by the HMBC correlations 
between H2-16/C-6, -7, -8 and H2-8/C-16. The hydroxy proton signal at H 2.84 was revealed by its 
1H–
1H  COSY  correlations  to  H-6  (H  4.21),  indicating  its  attachment  to  C-6.  The  location  of 
2-hydroxybutyrate group in 1 was confirmed by an HMBC correlation between H-4 (H 5.14) and the 
2-hydroxybutyrate carbonyl (C 171.4, s). Thus, the remaining acetate ester was at C-3, an oxygenated 
quaternary  carbon  which  bonded  to  the  C-15  tertiary  methyl  and  is  confirmed  by  the  HMBC 
correlations between H-2/C-15; H-4/C-15; and H3-15/C-2, -3, -4. The ether bridge between C-2 and 
C-9 was supported by an HMBC correlation between H-2/C-9. The 1-isopropyl-4-methylcyclohexene 
ring, which is fused to the ten-membered ring at C-1 and C-10, was elucidated by the 
1H–
1H COSY 
correlations between H-12/H2-13/H-14/H-1; H-14/H-18; and H-18/H3-19(H3-20) and further supported 
by the HMBC correlations between H-1/C-11, -14; H-2/C-14; H-10/C-11; H3-17/C-10; and H-18/C-1. 
The vinyl methyl at C-11 was confirmed by the HMBC correlations between H3-17/C-10, -11, -12 and 
further supported by the allylic coupling between the olefin proton H-12 and H3-17 (J = 0.8 Hz). 
Therefore, the planar structure of 1 was established. 
The  relative  configuration  of  1  was  elucidated  from  the  interactions  observed  in  a  NOESY 
experiment. In the NOESY experiment of 1 (Table 2), the correlations between H-1 with H-4 and 
H-10,  indicated  that  these  protons  are  situated  on  the  same  face  and  assigned  as    protons.  H-2 
exhibited  interactions  with  H-14  and  H3-15  and  no  correlation  was  found  between  H-1  and  H-2, 
indicating that H-2, H-14, and Me-15 should be -oriented. H-6 correlated with one proton of C-5 
methylene (H 2.97), but not with H-4, reflecting the -orientation of H-6. Furthermore, H-9 correlated 
with H2-8 and H3-17. From consideration of molecular models, H-9 was found to be reasonably close 
to H2-8 and H3-17, when H-9 was -oriented in 1. 
Table  2.  The stereoview of 1  (generated from computer modeling) and  the calculated 
distances (Å) between selected protons having key NOESY correlations.  
Cladielloide A (1)  H/H  (Å) 
 
H-1/H-4  2.59 
H-1/H-10  2.33 
H-2/H-14  2.45 
H-2/H3-15  2.32 
H-6/H-5  2.44 
H-8/H-9  2.44 
H-8/H-9  2.50 
H-9/H3-17  2.61 
In order to determine the absolute configuration, the eunicellin 1 was treated with (−) or (+)-MTPA 
chloride to yield the (S)- and (R)-MTPA esters 1a and 1b, respectively [12–14]. Comparison of the 
1H NMR chemical shifts for 1a and 1b (Δ values shown in Figure 1) led to the assignment of the 
S-configuration at C-6. The C-24 hydroxy group in the 2-hydroxybutyrate moiety was also assigned as 
R-configuration. Therefore, the absolute configurations of all chiral centers of 1 were assigned as 1R, 
2R, 3R, 4S, 6S, 9R, 10R, 14R, 24R. Mar. Drugs 2010, 8  
 
 
2940 
Figure 1. The key 
1H NMR chemical shift differences Δ (S–R) in ppm for the MTPA 
esters of 1. 
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Cladielloide B ( 2)  had  the  same  molecular  formula  as  that  of  1,  C26H40O7,  as  determined  by 
HRESIMS (C26H40O7 + Na, m/z 487.2675, calculated 487.2672). The spectral data (1D, 2D NMR 
(Table 3), IR, and MS) were similar to those of 1. However, the polarity of 2, which was checked by 
TLC, was substantially different from that of 1, indicating that these two compounds are isomers. In 
the 
1H NMR spectrum of 2, an acetate methyl was observed at H 2.14 (3H, s). The additional acyl 
group was found to be a 2-hydroxybutyrate group, which showed six contiguous protons (H 1.02, 3H, t, 
J = 7.2 Hz; 1.91, 2H, m; 4.87, 1H, dd, J = 6.8, 6.0 Hz). The 
13C NMR signal at C 170.2 (s) correlated 
with the signal of an oxymethine proton at H 4.87 in the HMBC spectrum and was consequently 
assigned as the carbon atom of the 2-hydroxybutyrate carbonyl. A correlation observed in the HMBC 
experiment of 2 further revealed the connectivity between H-4 (H 5.21) and the carbonyl carbon 
(C 170.2) of 2-hydroxybutyrate unit and demonstrated the location of the 2-hydroxybutyrate to be at 
C-4.  The  position  of  acetoxy  group  at  C-6  was  also  confirmed  by  the  connectivity  between  the 
oxymethine proton at H 4.66 (H-6) and the ester carbonyl at C 171.6 (s) in the HMBC spectrum of 2. 
Thus, the remaining hydroxy group should be positioned at C-3. In addition, by comparison of the 
NOESY correlations of 2 with those of 1, the chiral centers of 2 were confirmed to be the same as 
those of 1. 
Table 3. 
1H and 
13C NMR data, 
1H–
1H COSY, and HMBC correlations for diterpenoid 2. 
Position 
1H 
a  
13C 
b  
1H–
1H COSY  HMBC (H→C) 
1  2.51 m  40.6  (d) 
d  H-2, H-10, H-14  C-10 
2  3.90 d (3.6) 
c  88.1  (d)  H-1  C-1, -3, -4 
3    74.8  (s)     
4  5.21 dd (8.0, 4.0)  73.8  (d)  H2-5  C-6, -21 
5
 
2.48 m 
1.97 m 
34.2  (t)  H-4, H-5, H-6 
H-4, H-5, H-6 
C-6, -7 
n.o. 
e 
6  4.66 dd (8.8, 3.2)  83.8  (d)  H2-5  C-4, -7, -16, -25 
7    144.2  (s)     
8
 
2.65 dd (14.0, 4.8) 
2.46 dd (14.0, 2.0) 
41.4  (t)  H-8, H-9 
H-8, H-9 
C-6, -7, -9, -10, -16 
C-6, -7, -9, -10, -16 Mar. Drugs 2010, 8  
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Table 3. Cont. 
9  4.06 br s  82.4  (d)  H2-8, H-10  n.o. 
10  2.58 br s  44.7  (d)  H-1, H-9  C-8, -9, -11 
11    131.1  (s)     
12  5.49 m  123.1  (d)  H2-13, H3-17  n.o. 
13
 
2.01 m 
1.80 m 
22.9  (t)  H-12, H-13, H-14
H-12, H-13, H-14 
n.o. 
n.o. 
14  1.39 m  39.8  (d)  H-1, H2-13, H-18  C-2 
15  1.33 s  22.8  (q)    C-2, -3, -4 
16a 
b 
5.26 s 
5.47 s 
117.7  (t)  H-16b 
H-16a 
C-6, -8 
C-6, -7, -8 
17  1.69 d (1.2)  22.8  (q)  H-12  C-10, -11, -12 
18  1.80 m  27.8  (d)  H-14, H3-19, H3-20  C-14, -19, -20 
19  0.94 d (6.8)  21.7  (q)  H-18  C-14, -18, -20 
20  0.77 d (6.8)  17.5  (q)  H-18  C-14, -19, -20 
OCCHCH2CH3
O
OH
4-
21
22 23 24
 
 
4.87 dd (6.8, 6.0) 
1.91 m 
1.02 t (7.2) 
170.2 
74.3 
24.5 
9.3 
(s) 
(d) 
(t) 
(q) 
 
H2-23 
H-22, H3-24 
H2-23 
 
C-21, -23, -24 
C-21, -22, -24 
C-22, -23 
6-OC(O)CH3 
25 26 
 
2.14 s 
171.6 
20.6 
(s) 
(q) 
   
C-25 
a Spectra measured at 400 MHz in CDCl3 at 25 °C ; 
b Spectra measured at 100 MHz in CDCl3 at 
25 °C ; 
c J values (in hertz) in parentheses; 
d Attached protons were deduced by DEPT and HMQC 
experiments; 
e n.o. = not observed. 
The cytotoxicity of metabolites 1 and 2 toward various tumor cell lines, including DLD-1, HL-60, 
CCRF-CEM  (human  T-cell  acute  lymphoblastic  leukemia),  and  P388D1  cells  was  evaluated.  The 
results, in Table 4, show that eunicellin 2 exhibited moderate cytotoxicity toward CCRF-CEM cells. 
Table 4. Cytotoxic data of diterpenoids 1 and 2. 
Compound 
Cell lines IC50 (g/mL) 
DLD-1  HL-60  CCRF-CEM  P388D1 
1  >40  >40  >40  >40 
2  10.2  >40  4.7  >40 
Doxorubicin 
a  0.09  0.03  0.18  0.11 
a Doxorubicin was used as a reference compound. 
The in vitro anti-inflammatory effects of metabolites 1 and 2 were tested. Metabolite 2 displayed 
significant inhibitory effects on superoxide anion generation and elastase release by human neutrophils 
at 10g/mL (Table 5). Mar. Drugs 2010, 8  
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Table 5. Inhibitory effects of diterpenoids 1 and 2 on superoxide anion generation and 
elastase release by human neutrophils in response to FMLP/CB. 
Compound 
Superoxide anion  Elastase release 
IC50 (g/mL) 
a or (Inh %) 
b  IC50 (g/mL) or (Inh %) 
1  (20.5 ±  5.0)  (27.1 ±  4.8) 
2  5.9 ±  0.7  6.5 ±  1.9 
DPI 
c  0.8 ±  0.2   
Elastatinal 
c    30.8 ±  5.7 
a  Concentration  necessary  for  50%  inhibition  (IC50); 
b  Percentage  of  inhibition  (Inh  %)  at 
10 g/mL; 
c DPI (diphenylene indonium) and elastatinal were used as reference compounds. 
3. Experimental  
3.1. General Experimental Procedures 
Optical rotation values were measured with a JASCO P-1010 digital polarimeter at 25 ° C. Infrared 
spectra were obtained on a VARIAN DIGLAB FTS 1000 FT-IR spectrometer. The NMR spectra were 
recorded on a VARIAN MERCURY PLUS 400 FT-NMR at 400 MHz for 
1H and 100 MHz for 
13C, in 
CDCl3 at 25 °C . Proton chemical shifts were referenced to the residual CHCl3 signal ( 7.26 ppm). 
13C NMR spectra were referenced to the center peak of CDCl3 at C 77.1 ppm. ESIMS and HRESIMS 
data  were  recorded  on  a  BRUKER  APEX  II  mass  spectrometer.  Column  chromatography  was 
performed  on  silica  gel  (230–400  mesh,  Merck,  Darmstadt,  Germany).  TLC  was  carried  out  on 
precoated Kieselgel 60 F254 (0.25 mm, Merck) and spots were visualized by spraying with 10% H2SO4 
solution followed by heating. HPLC was performed using a system comprised of a HITACHI L-7100 
pump, a HITACHI  photodiode array detector  L-7455, and a  RHEODYNE 7725 injection  port. A 
normal phase column (Hibar 250 ×  10 mm, Merck, silica gel 60, 5 m,) was used for HPLC. 
3.2. Animal Material  
The octocoral Cladiella sp. were collected from Indonesia in 2004 and stored in a freezer until 
extraction.  A  voucher  specimen  was  deposited  in  the  National  Museum  of  Marine  Biology  and 
Aquarium,  Taiwan  (NMMBA).  This  organism  was  identified  by  comparison  with  previous 
descriptions [15,16]. 
3.3. Extraction and Isolation 
Slices of Cladiella sp. (wet weight 924 g) were extracted with a mixture of MeOH and CH2Cl2 (1:1) 
and the residue was partitioned between EtOAc and H2O. The EtOAc layer was subjected to silica gel 
column chromatography and eluted using a mixture of n-hexane and EtOAc (stepwise, 100:1 to pure 
EtOAc) to obtain 19 fractions A–S. Fractions K and N were repurified by normal phase HPLC, using 
the mixture of n-hexane/ethyl acetate to afford 2 (2.4 mg, 5.5:1) and 1 (7.9 mg, 3:1), respectively. 
Cladielloide  A  (1).  Colorless  oil;  [α]
23
D −24°   (c  0.4,  CHCl3);  IR  (neat)max  3460,  1734  cm
−1; 
1H (CDCl3, 400 MHz) and 
13C (CDCl3, 100 MHz) NMR data, see Table 1; ESIMS m/z 487 (M + Na)
+; 
HRESIMS m/z 487.2674 (calculated for C26H40O7 + Na, 487.2672). Mar. Drugs 2010, 8  
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Cladielloide  B  (2).  Colorless  oil;  []
23
D −10°   (c  0.1,  CHCl3);  IR  (neat)max  3446,  1738  cm
−1; 
1H (CDCl3, 400 MHz) and 
13C (CDCl3, 100 MHz) NMR data, see Table 3; ESIMS m/z 487 (M + Na)
+; 
HRESIMS m/z 487.2675 (calculated for C26H40O7 + Na, 487.2672).  
3.4. Preparation of (S)- and (R)-MTPA Esters of Cladielloide A (1) 
To a solution of 1 (1 mg) in pyridine (0.4 mL), R-(−)--methoxy--(trifluoromethyl) phenylacetyl 
(MPTA)  chloride  (25  L)  was  added,  and  the  mixture  was  allowed  to  stand  for  24  h  at  room 
temperature.  The  reaction  was  quenched  by  addition  of  1.0  mL  of  water,  and  the  mixture  was 
subsequently extracted with EtOAc (3 ×  1.0 mL). The EtOAc-soluble layers were combined, dried 
over anhydrous MgSO4 and evaporated. The residue was subjected to column chromatography over 
silica gel using n-hexane–EtOAc (13:2) to yield the (S)-MTPA ester, 1a (0.7 mg, 44%). The same 
procedure was used to prepare the (R)-MTPA ester, 1b (1.4 mg, 89%), from the reaction of (S)-MPTA 
chloride with 1 in pyridine. The key 
1H NMR chemical shift differences Δ (S − R) in ppm for the 
MTPA esters of 1 are shown in Figure 1.  
3.5. Cytotoxicity Testing 
The  cytotoxicity  of  compounds  1  and  2  was  assayed  with  a  modification  of  the  MTT  
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium  bromide]  colorimetric  method.  Cytotoxicity 
assays was carried out according to the procedures described previously [17,18]. 
3.6. Human Neutrophil Superoxide Anion Generation and Elastase Release 
Human neutrophils were obtained by means of dextran sedimentation and Ficoll centrifugation. 
Superoxide generation and elastase release were carried out according to the procedures described 
previously [19,20]. Briefly, superoxide anion production was assayed by monitoring the superoxide 
dismutase-inhibitable reduction of ferricytochrome c. Elastase release experiments were performed 
using MeO-Suc-Ala-Ala-Pro-Valp-nitroanilide as the elastase substrate. 
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